BlackRock Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.32M	Buy	45,695 +9,259	+25%	+$245K	﹤0.01%	2508
2016 Q3	$1.16M	Buy	36,436 +1,067	+3%	+$36.2K	﹤0.01%	2568
2016 Q2	$1.15M	Sell	35,369 -258,595	-88%	-$8.65M	﹤0.01%	2527
2016 Q1	$8.22M	Buy	293,964 +12,124	+4%	+$264K	0.01%	1045
2015 Q4	$10M	Buy	281,840 +1,515	+0.5%	+$53.4K	0.01%	938
2015 Q3	$9.27M	Sell	280,325 -3,357	-1%	-$140K	0.01%	973
2015 Q2	$11.9M	Buy	283,682 +63,974	+29%	+$2.48M	0.01%	892
2015 Q1	$7.16M	Buy	219,708 +2,985	+1%	+$103K	0.01%	1152
2014 Q4	$6.88M	Sell	216,723 -1,783	-0.8%	-$50.6K	0.01%	1167
2014 Q3	$5.41M	Sell	218,506 -28,144	-11%	-$658K	0.01%	1285
2014 Q2	$5.57M	Buy	246,650 +30,840	+14%	+$644K	0.01%	1314
2014 Q1	$5.25M	Buy	215,810 +20,727	+11%	+$524K	0.01%	1331
2013 Q4	$4.88M	Sell	195,083 -4,992	-2%	-$118K	0.01%	1367
2013 Q3	$5.5M	Buy	200,075 +11,589	+6%	+$242K	0.01%	1224
2013 Q2	$3.42M	Buy	+188,486	New	+$2.6M	0.01%	1469